back and body extra strength
Generic: aspirin, caffeine
Labeler: l.n.k. international, inc.Drug Facts
Product Profile
Brand Name
back and body extra strength
Generic Name
aspirin, caffeine
Labeler
l.n.k. international, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
aspirin 500 mg/1, caffeine 32.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50844-413
Product ID
50844-413_d7b34f4a-3a1e-425b-be40-ad94bd3d5cd1
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2004-04-12
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50844413
Hyphenated Format
50844-413
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
back and body extra strength (source: ndc)
Generic Name
aspirin, caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
- 32.5 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (50844-413-08) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 1 BOTTLE, PLASTIC in 1 CARTON (50844-413-09) / 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d7b34f4a-3a1e-425b-be40-ad94bd3d5cd1", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0350844413802"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["702316"], "spl_set_id": ["6d254f3f-8223-4a6e-a3b2-f53f145ff3dc"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["L.N.K. International, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (50844-413-08) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "50844-413-08", "marketing_start_date": "20040412"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (50844-413-09) / 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "50844-413-09", "marketing_start_date": "20040412"}], "brand_name": "Back and Body Extra Strength", "product_id": "50844-413_d7b34f4a-3a1e-425b-be40-ad94bd3d5cd1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "50844-413", "generic_name": "Aspirin, Caffeine", "labeler_name": "L.N.K. International, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Back and Body", "brand_name_suffix": "Extra Strength", "active_ingredients": [{"name": "ASPIRIN", "strength": "500 mg/1"}, {"name": "CAFFEINE", "strength": "32.5 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20040412", "listing_expiration_date": "20261231"}